Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Octreotide for prevention of postoperative pancreatic fistula after pancreaticoduodenectomy
ChiCTR2000029555Phase 4Recruiting
- Sponsor
- Renji Hospital
- Start
- Mar 2019
- Modality
- Peptides
- Countries
- 1
01
Overview
Phase 4, randomised, double-blind trial of octreotide in pancreatic fistula (POPF) (2 arms), sponsored by Renji Hospital. Primary endpoints: Blood amylase and Amylase in drainage fluid. Started Mar 2019; status: recruiting.
02
Drugs
octreotide
03
Conditions
pancreatic fistula (POPF)
Beyond the preview
Go deeper on ChiCTR2000029555.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ChiCTR2000029555.